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Very low birth weight
preterm infant
Summary
Background: Leukoerythroblastosis is characterized by the presence of leukocytosis and ery-
throid and myeloid blast cells in the peripheral blood. The most common etiological factors of
leukoerythroblastosis occurring during early childhood are viral infections, juvenile myelomo-
nocytic leukemia, and osteopetrosis. To our knowledge, an association with parvovirus B19
infection has only been reported in a preterm infant. Human parvovirus B19 has been associated
with red cell aplasia, leukopenia, and thrombocytopenia.
Case report: The case of a very low birth weight preterm infant with transient leukoerythro-
blastosis associated with parvovirus B19 infection is described.
Conclusions: Leukoerythroblastosis has to be kept in mind if a very high leukocyte count is
detected in the neonatal period, and parvovirus B19 infection should be taken into consideration
as the etiological factor for this entity.
# 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
Leukoerythroblastosis is an uncommon disease characterized
by the presence of leukocytosis and erythroid and myeloid
blast cells in the peripheral blood. It has been reported in
association with juvenile myelomonocytic leukemia, hemo-
lytic anemia, osteopetrosis, myelofibrosis, and neuroblas-
toma in the newborn and during childhood.1,2 The most
common etiological factors for leukoerythroblastosis occur-* Corresponding author. Tel.: +90 284 235 76 41/4917;
fax: +90 284 235 23 38.
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doi:10.1016/j.ijid.2009.01.002ring during early childhood are viral infections, juvenile
myelomonocytic leukemia, and osteopetrosis. Human parvo-
virus B19 infection has been associated with red cell aplasia,
leukopenia, and thrombocytopenia. Parvovirus B19 infects
the erythroid progenitor cells and causes transient erythro-
blastopenia and may present as erythema infectiosum in
children. However, a transient increase in leukocyte and
platelet counts has also been reported.1,3,4 Leukoerythro-
blastosis has been reported in association with infection by
parvovirus B19 in a preterm infant.1 We describe herein the
case of a very low birth weight (780 g) infant who had a high
leukocyte count with transient leukoerythroblastosis asso-
ciated with parvovirus B19 infection.Published by Elsevier Ltd. All rights reserved.
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A preterm male infant was born vaginally at 26 weeks of
gestation to a 35-year-old gravida 1 mother. His mother had
been followed-up routinely by her private obstetrician, had
shown a normal pregnancy course until delivery, and had
received antenatal steroids for the prevention of respiratory
distress syndrome. Apgar scores were 4 at 1 minute and 6 at
5 minutes. His birth weight was 780 g (10—50th percentile),
height 32 cm (10—50th percentile), and head circumference
23 cm (10—50th percentile). On admission to our neonatal
unit, the infant was tachypneic and had severe retractions,
nasal flaring, and grunting. A chest radiograph showed opaque
lungs; therefore one dose of surfactant was administered
within 1 hour after birth and he was put on mechanical
ventilation. Routine laboratory measurements revealed
hyperleukocytosis (140  109/l) andmild anemia (hemoglobin
11.2 g/dl and hematocrit 34.4%). His platelet count was nor-
mal. The peripheral blood smear showed 3% myeloblasts, 2%
promyelocytes, 3% myelocytes, 25% metamyelocytes, 8%
band, 40% neutrophils, 12% lymphocytes, 5% monocytes, 2%
eosinophils, 9% orthochromatophilic erythroblasts, and 2%Figure 1 Peripheral blood smear shows leukocytosis and ery-
throid blast cells (4  102).
Figure 2 Peripheral blood smear shows leukocytosis and mye-
loid blast cell (10  102).polychromatophilic erythroblasts (Figures 1 and 2). The per-
ipheral blood smear suggested leukoerythroblastosis with the
presence of severe leukocytosis, erythroblastosis, and myelo-
blastosis. The absolute reticulocyte count was found to be
69.4  109/l. The direct Coombs test was negative and bilir-
ubin levels were within the normal range. On bone marrow
aspiration, cellularity and cytogenetic examination were nor-
mal. Parvovirus B19 IgMand IgG serologywas positive (1/16) on
day 2 and week 2 of life, both in the mother and the baby. The
serological diagnosis of parvovirus B19 infection was per-
formed by immunofluorescence assay (IFA) method (Biotrin,
Dublin, Ireland). TORCH panel and Epstein—Barr virus serology
were negative. Leukocyte count and peripheral blood smear
results became normal at day 10. However he continued to
require ventilatory support and developed chronic lung dis-
ease at week 4 of life. He is currently 55 days old and remains
on continuous mechanical ventilatory support.
Discussion
The hematological profile of our case was interpreted as
severe leukocytosis and mild anemia. The peripheral blood
smear suggested leukoerythroblastosis with the presence of
severe leukocytosis, erythroblastosis, and myeloblastosis.
Hemolytic anemia was ruled out because reticulocytosis
was absent, the direct Coombs test was negative, and bilir-
ubin levels were within the normal range. Preterm delivery
and leukoerythroblastosis were considered to have devel-
oped secondary to parvovirus B19 infection.
Leukoerythroblastosis is a clinical manifestation observed
rarely during childhood, with various etiological factors. The
etiological factors during early childhood are congenital—
postnatal viral infections, juvenile myelomonocytic leuke-
mia, myelofibrosis, and osteopetrosis.1,2,5 Acute parvovirus
B19 infection may present as erythema infectiosum in chil-
dren. Parvovirus B19 infects the erythroid progenitor cells
and causes transient erythroblastopenia and is usually asso-
ciated with red cell aplasia, leukopenia, and thrombocyto-
penia. However, transient increases in leukocyte and platelet
counts have also been reported.3,4
In the literature, leukoerythroblastosis has been reported
inonlyone1164 gpreterminfant inassociationwithparvovirus
B19 infection; the infanthada leukocyte count of 85  109/l at
29weeks of gestation.1 Our case also had a very high leukocyte
count (140  109/l) with leukoerythroblastosis. A malignant
etiology and osteopetrosis were not taken into consideration
because of normal findings on cytogenetic analysis and the
absence of severe anemia, thrombocytopenia, and hepatos-
plenomegaly. Myelomonocytic leukemia was ruled out as the
leukocyte count and peripheral smear results regressed spon-
taneously.1 It has recently been reported that infections such
as parvovirus B19 developing in pregnancy may have a severe
course.6,7 In our case, preterm delivery and leukoerythroblas-
tosis were considered to have developed secondary to intrau-
terine parvovirus B19 infection.
Chronic lung disease has recently been reported in cases
with a leukocyte count greater than 50  109/l. Leukocytosis
in the first days of life may reflect the presence of an
intrauterine infection, triggering the development of chronic
lung disease after birth.8,9 The development of chronic lung
disease in our case supports this suggestion.
Transient leukoerythroblastosis during the neonatal period e475In conclusion, we have described the case of a preterm
infant with transient leukoerythroblastosis associated with
parvovirus B19 infection. Leukoerythroblastosis has to be kept
in mind if a very high leukocyte count is detected in the
neonatal period, and parvovirus B19 infection should be taken
into consideration as the etiological factor for this entity.
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